Articles on human papillomavirus vaccines from NPS RADARArticles on human papillomavirus vaccines from NPS RADAR

Title Content Type Date Description
Second human papillomavirus vaccine (Cervarix) included on the National Immunisation Program Professional publication - NPS RADAR - Brief item 2008-12-01 00:00:00 A second human papillomavirus (HPV) vaccine (Cervarix) has been accepted for use through the National HPV Vaccination Program.
Quadrivalent human papillomavirus vaccine (Gardasil) Professional publication - NPS RADAR - Review 2007-07-01 00:00:00 Reviews use of human papillomavirus vaccine for prevention of HPV-related cervical cancer, including immunisation program for adolescents and young women.
Title Content Type Date Description
Second human papillomavirus vaccine (Cervarix) included on the National Immunisation Program Professional publication - NPS RADAR - Brief item 2008-12-01 00:00:00 A second human papillomavirus (HPV) vaccine (Cervarix) has been accepted for use through the National HPV Vaccination Program.
Quadrivalent human papillomavirus vaccine (Gardasil) Professional publication - NPS RADAR - Review 2007-07-01 00:00:00 Reviews use of human papillomavirus vaccine for prevention of HPV-related cervical cancer, including immunisation program for adolescents and young women.

NPS RADAR: independent, evidence-based assessment of new drugs, new PBS listings and the latest research for doctors, pharmacists and other health professionals.

Date published: 2009-10-30 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.